Efficacy of tocilizumab in rituximab-refractory cryoglobulinemia vasculitis.
Identifieur interne : 000506 ( Ncbi/Checkpoint ); précédent : 000505; suivant : 000507Efficacy of tocilizumab in rituximab-refractory cryoglobulinemia vasculitis.
Auteurs : Camille Cohen ; Arsene Mekinian ; Nathalie Saidenberg-Kermanac'H ; Jerôme Stirnemann ; Pierre Fenaux ; Romain Gherardi ; Olivier FainSource :
- Annals of the rheumatic diseases [ 1468-2060 ] ; 2012.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen, Anticorps monoclonaux d'origine murine (usage thérapeutique), Anticorps monoclonaux humanisés (usage thérapeutique), Cryoglobulinémie (traitement médicamenteux), Facteurs immunologiques (usage thérapeutique), Humains, Mâle, Rituximab, Résistance aux substances, Vascularite (traitement médicamenteux).
- MESH :
- traitement médicamenteux : Cryoglobulinémie, Vascularite.
- usage thérapeutique : Anticorps monoclonaux d'origine murine, Anticorps monoclonaux humanisés, Facteurs immunologiques.
- Adulte d'âge moyen, Humains, Mâle, Rituximab, Résistance aux substances.
English descriptors
- KwdEn :
- MESH :
- chemical , therapeutic use : Antibodies, Monoclonal, Humanized, Antibodies, Monoclonal, Murine-Derived, Immunologic Factors.
- drug therapy : Cryoglobulinemia, Vasculitis.
- Drug Resistance, Humans, Male, Middle Aged, Rituximab.
DOI: 10.1136/annrheumdis-2011-200501
PubMed: 22121135
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001938
- to stream PubMed, to step Curation: 001938
- to stream PubMed, to step Checkpoint: 001773
- to stream Ncbi, to step Merge: 000506
- to stream Ncbi, to step Curation: 000506
Links to Exploration step
pubmed:22121135Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Efficacy of tocilizumab in rituximab-refractory cryoglobulinemia vasculitis.</title><author><name sortKey="Cohen, Camille" sort="Cohen, Camille" uniqKey="Cohen C" first="Camille" last="Cohen">Camille Cohen</name></author><author><name sortKey="Mekinian, Arsene" sort="Mekinian, Arsene" uniqKey="Mekinian A" first="Arsene" last="Mekinian">Arsene Mekinian</name></author><author><name sortKey="Saidenberg Kermanac H, Nathalie" sort="Saidenberg Kermanac H, Nathalie" uniqKey="Saidenberg Kermanac H N" first="Nathalie" last="Saidenberg-Kermanac'H">Nathalie Saidenberg-Kermanac'H</name></author><author><name sortKey="Stirnemann, Jerome" sort="Stirnemann, Jerome" uniqKey="Stirnemann J" first="Jerôme" last="Stirnemann">Jerôme Stirnemann</name></author><author><name sortKey="Fenaux, Pierre" sort="Fenaux, Pierre" uniqKey="Fenaux P" first="Pierre" last="Fenaux">Pierre Fenaux</name></author><author><name sortKey="Gherardi, Romain" sort="Gherardi, Romain" uniqKey="Gherardi R" first="Romain" last="Gherardi">Romain Gherardi</name></author><author><name sortKey="Fain, Olivier" sort="Fain, Olivier" uniqKey="Fain O" first="Olivier" last="Fain">Olivier Fain</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2012">2012</date><idno type="RBID">pubmed:22121135</idno><idno type="pmid">22121135</idno><idno type="doi">10.1136/annrheumdis-2011-200501</idno><idno type="wicri:Area/PubMed/Corpus">001938</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001938</idno><idno type="wicri:Area/PubMed/Curation">001938</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001938</idno><idno type="wicri:Area/PubMed/Checkpoint">001773</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001773</idno><idno type="wicri:Area/Ncbi/Merge">000506</idno><idno type="wicri:Area/Ncbi/Curation">000506</idno><idno type="wicri:Area/Ncbi/Checkpoint">000506</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Efficacy of tocilizumab in rituximab-refractory cryoglobulinemia vasculitis.</title><author><name sortKey="Cohen, Camille" sort="Cohen, Camille" uniqKey="Cohen C" first="Camille" last="Cohen">Camille Cohen</name></author><author><name sortKey="Mekinian, Arsene" sort="Mekinian, Arsene" uniqKey="Mekinian A" first="Arsene" last="Mekinian">Arsene Mekinian</name></author><author><name sortKey="Saidenberg Kermanac H, Nathalie" sort="Saidenberg Kermanac H, Nathalie" uniqKey="Saidenberg Kermanac H N" first="Nathalie" last="Saidenberg-Kermanac'H">Nathalie Saidenberg-Kermanac'H</name></author><author><name sortKey="Stirnemann, Jerome" sort="Stirnemann, Jerome" uniqKey="Stirnemann J" first="Jerôme" last="Stirnemann">Jerôme Stirnemann</name></author><author><name sortKey="Fenaux, Pierre" sort="Fenaux, Pierre" uniqKey="Fenaux P" first="Pierre" last="Fenaux">Pierre Fenaux</name></author><author><name sortKey="Gherardi, Romain" sort="Gherardi, Romain" uniqKey="Gherardi R" first="Romain" last="Gherardi">Romain Gherardi</name></author><author><name sortKey="Fain, Olivier" sort="Fain, Olivier" uniqKey="Fain O" first="Olivier" last="Fain">Olivier Fain</name></author></analytic><series><title level="j">Annals of the rheumatic diseases</title><idno type="eISSN">1468-2060</idno><imprint><date when="2012" type="published">2012</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antibodies, Monoclonal, Humanized (therapeutic use)</term><term>Antibodies, Monoclonal, Murine-Derived (therapeutic use)</term><term>Cryoglobulinemia (drug therapy)</term><term>Drug Resistance</term><term>Humans</term><term>Immunologic Factors (therapeutic use)</term><term>Male</term><term>Middle Aged</term><term>Rituximab</term><term>Vasculitis (drug therapy)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Anticorps monoclonaux d'origine murine (usage thérapeutique)</term><term>Anticorps monoclonaux humanisés (usage thérapeutique)</term><term>Cryoglobulinémie (traitement médicamenteux)</term><term>Facteurs immunologiques (usage thérapeutique)</term><term>Humains</term><term>Mâle</term><term>Rituximab</term><term>Résistance aux substances</term><term>Vascularite (traitement médicamenteux)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antibodies, Monoclonal, Humanized</term><term>Antibodies, Monoclonal, Murine-Derived</term><term>Immunologic Factors</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Cryoglobulinemia</term><term>Vasculitis</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Cryoglobulinémie</term><term>Vascularite</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Anticorps monoclonaux d'origine murine</term><term>Anticorps monoclonaux humanisés</term><term>Facteurs immunologiques</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Drug Resistance</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Rituximab</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Humains</term><term>Mâle</term><term>Rituximab</term><term>Résistance aux substances</term></keywords></textClass></profileDesc></teiHeader></TEI><affiliations><list></list><tree><noCountry><name sortKey="Cohen, Camille" sort="Cohen, Camille" uniqKey="Cohen C" first="Camille" last="Cohen">Camille Cohen</name><name sortKey="Fain, Olivier" sort="Fain, Olivier" uniqKey="Fain O" first="Olivier" last="Fain">Olivier Fain</name><name sortKey="Fenaux, Pierre" sort="Fenaux, Pierre" uniqKey="Fenaux P" first="Pierre" last="Fenaux">Pierre Fenaux</name><name sortKey="Gherardi, Romain" sort="Gherardi, Romain" uniqKey="Gherardi R" first="Romain" last="Gherardi">Romain Gherardi</name><name sortKey="Mekinian, Arsene" sort="Mekinian, Arsene" uniqKey="Mekinian A" first="Arsene" last="Mekinian">Arsene Mekinian</name><name sortKey="Saidenberg Kermanac H, Nathalie" sort="Saidenberg Kermanac H, Nathalie" uniqKey="Saidenberg Kermanac H N" first="Nathalie" last="Saidenberg-Kermanac'H">Nathalie Saidenberg-Kermanac'H</name><name sortKey="Stirnemann, Jerome" sort="Stirnemann, Jerome" uniqKey="Stirnemann J" first="Jerôme" last="Stirnemann">Jerôme Stirnemann</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Ncbi/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000506 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd -nk 000506 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= TocilizumabV1
|flux= Ncbi
|étape= Checkpoint
|type= RBID
|clé= pubmed:22121135
|texte= Efficacy of tocilizumab in rituximab-refractory cryoglobulinemia vasculitis.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/RBID.i -Sk "pubmed:22121135" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a TocilizumabV1
| This area was generated with Dilib version V0.6.34. |  |